IL133075A0 - Gelatine encapsulated solution dosage forms of sertraline - Google Patents

Gelatine encapsulated solution dosage forms of sertraline

Info

Publication number: IL133075A0
Authority: IL; Israel
Prior art keywords: sertraline; dosage forms; solution dosage; encapsulated solution; gelatine encapsulated
Prior art date: 1997-07-01

Application number

IL13307598A

Other languages

English (en)

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1998-06-16

Publication date

2001-03-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL133075(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-06-16 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2001-03-19 Publication of IL133075A0 publication Critical patent/IL133075A0/xx

Links

239000001828 Gelatine Substances 0.000 title 1
239000002552 dosage form Substances 0.000 title 1
229920000159 gelatin Polymers 0.000 title 1
235000019322 gelatine Nutrition 0.000 title 1
VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 title 1
229960002073 sertraline Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Hematology (AREA)
Obesity (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Child & Adolescent Psychology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

IL13307598A 1997-07-01 1998-06-16 Gelatine encapsulated solution dosage forms of sertraline IL133075A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5140197P	1997-07-01	1997-07-01
PCT/IB1998/000936 WO1999001113A1 (fr)	1997-07-01	1998-06-16	Formes posologiques de sertraline, en solution et encapsulees dans de la gelatine

Publications (1)

Publication Number	Publication Date
IL133075A0 true IL133075A0 (en)	2001-03-19

Family

ID=21971076

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL13307598A IL133075A0 (en)	1997-07-01	1998-06-16	Gelatine encapsulated solution dosage forms of sertraline

Country Status (40)

Country	Link
EP (1)	EP0980241B1 (fr)
JP (1)	JP3585245B2 (fr)
KR (1)	KR100371730B1 (fr)
CN (1)	CN1261792A (fr)
AP (1)	AP945A (fr)
AR (1)	AR015916A1 (fr)
AT (1)	ATE256457T1 (fr)
AU (1)	AU724635B2 (fr)
BG (1)	BG103917A (fr)
BR (1)	BR9809712A (fr)
CA (1)	CA2290973C (fr)
CO (1)	CO4940405A1 (fr)
DE (1)	DE69820608T2 (fr)
DK (1)	DK0980241T3 (fr)
DZ (1)	DZ2544A1 (fr)
EA (1)	EA001905B1 (fr)
ES (1)	ES2210760T3 (fr)
GT (1)	GT199800090A (fr)
HR (1)	HRP980378B1 (fr)
HU (1)	HUP0002250A3 (fr)
ID (1)	ID24673A (fr)
IL (1)	IL133075A0 (fr)
IS (1)	IS5266A (fr)
MA (1)	MA24586A1 (fr)
MY (1)	MY119728A (fr)
NO (1)	NO996492L (fr)
NZ (1)	NZ501252A (fr)
OA (1)	OA11246A (fr)
PA (1)	PA8454001A1 (fr)
PE (1)	PE97299A1 (fr)
PL (1)	PL337807A1 (fr)
PT (1)	PT980241E (fr)
SK (1)	SK282914B6 (fr)
TN (1)	TNSN98123A1 (fr)
TR (1)	TR199903282T2 (fr)
TW (1)	TW382597B (fr)
UA (1)	UA68350C2 (fr)
UY (1)	UY25070A1 (fr)
WO (1)	WO1999001113A1 (fr)
ZA (1)	ZA985709B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA72743C2 (en) *	1998-10-13	2005-04-15	Pfizer Prod Inc	Essentially nonaqueous liquid pharmaceutical concentrate composition containing sertraline, method of using this concentrate, method for treatment
US6727283B2 (en)	1998-10-13	2004-04-27	Pfizer Inc.	Sertraline oral concentrate
EP1671628B1 (fr)	1999-09-03	2012-10-03	APBI Holdings, LLC	Inhibiteurs de réabsorption de sérotonine à action rapide pour le traitement des dysfonctions sexuelles
CA2420535A1 (fr)	2000-08-30	2002-03-07	Mary Tanya Am Ende	Formulations a liberation prolongee pour les secretagogues de l'hormone de croissance
EP1375659A1 (fr) *	2002-06-18	2004-01-02	Laboratorio di Diagnostica Moleculare	Mélanges concentrés dans des capsules solubles pour la préparation facilitée de solutions chimiques ou biologiques
AU2003291667A1 (en) *	2002-10-31	2004-06-07	Alza Corporation	Pharmaceutical formulation providing an increased bioavailability of hydrophobic drugs
WO2016020936A2 (fr) *	2014-07-21	2016-02-11	Patel Jayendrakumar Dasharathlal	Nouvelle forme posologique pharmaceutique orale de rétention gastrique
CN108014087A (zh) *	2017-12-27	2018-05-11	江苏联环药业股份有限公司	一种盐酸舍曲林胶囊的制备方法
GB2630572A (en)	2023-05-29	2024-12-04	Novumgen Ltd	An orally disintegrating tablet of sertraline and its process of preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0782445T3 (da) *	1994-09-19	2002-05-06	Bristol Myers Squibb Pharma Co	Kombination af en opioidantagonist og en selektiv serotoningenoptagelsesinhibitor til behandling af alkoholisme og alkoholafhængighed
ATE235237T1 (de) *	1995-07-17	2003-04-15	Pfizer	Sertralin zur behandlung von post-myocard-infarkt-patienten

1998
- 1998-06-16 TR TR1999/03282T patent/TR199903282T2/xx unknown
- 1998-06-16 IL IL13307598A patent/IL133075A0/xx unknown
- 1998-06-16 AT AT98923021T patent/ATE256457T1/de not_active IP Right Cessation
- 1998-06-16 DK DK98923021T patent/DK0980241T3/da active
- 1998-06-16 HU HU0002250A patent/HUP0002250A3/hu unknown
- 1998-06-16 BR BR9809712-1A patent/BR9809712A/pt not_active Application Discontinuation
- 1998-06-16 NZ NZ501252A patent/NZ501252A/en unknown
- 1998-06-16 PL PL98337807A patent/PL337807A1/xx unknown
- 1998-06-16 PT PT98923021T patent/PT980241E/pt unknown
- 1998-06-16 CA CA002290973A patent/CA2290973C/fr not_active Expired - Fee Related
- 1998-06-16 UA UA99116393A patent/UA68350C2/uk unknown
- 1998-06-16 EP EP98923021A patent/EP0980241B1/fr not_active Expired - Lifetime
- 1998-06-16 AU AU75450/98A patent/AU724635B2/en not_active Ceased
- 1998-06-16 SK SK1805-99A patent/SK282914B6/sk unknown
- 1998-06-16 EA EA199900963A patent/EA001905B1/ru not_active IP Right Cessation
- 1998-06-16 CN CN98806765A patent/CN1261792A/zh active Pending
- 1998-06-16 ID IDW991697A patent/ID24673A/id unknown
- 1998-06-16 ES ES98923021T patent/ES2210760T3/es not_active Expired - Lifetime
- 1998-06-16 JP JP50677699A patent/JP3585245B2/ja not_active Expired - Fee Related
- 1998-06-16 WO PCT/IB1998/000936 patent/WO1999001113A1/fr not_active Ceased
- 1998-06-16 KR KR10-1999-7011596A patent/KR100371730B1/ko not_active Expired - Fee Related
- 1998-06-16 DE DE69820608T patent/DE69820608T2/de not_active Expired - Fee Related
- 1998-06-19 PA PA19988454001A patent/PA8454001A1/es unknown
- 1998-06-25 TW TW087110254A patent/TW382597B/zh not_active IP Right Cessation
- 1998-06-25 AP APAP/P/1998/001279A patent/AP945A/en active
- 1998-06-26 PE PE1998000575A patent/PE97299A1/es not_active Application Discontinuation
- 1998-06-29 AR ARP980103145A patent/AR015916A1/es not_active Application Discontinuation
- 1998-06-29 MY MYPI98002949A patent/MY119728A/en unknown
- 1998-06-29 GT GT199800090A patent/GT199800090A/es unknown
- 1998-06-29 UY UY25070A patent/UY25070A1/es not_active IP Right Cessation
- 1998-06-30 ZA ZA9805709A patent/ZA985709B/xx unknown
- 1998-06-30 TN TNTNSN98123A patent/TNSN98123A1/fr unknown
- 1998-06-30 MA MA25145A patent/MA24586A1/fr unknown
- 1998-06-30 DZ DZ980154A patent/DZ2544A1/fr active
- 1998-07-01 HR HR980378A patent/HRP980378B1/xx not_active IP Right Cessation
- 1998-07-01 CO CO98037136A patent/CO4940405A1/es unknown
1999
- 1999-11-23 IS IS5266A patent/IS5266A/is unknown
- 1999-11-23 BG BG103917A patent/BG103917A/bg unknown
- 1999-12-23 OA OA9900306A patent/OA11246A/en unknown
- 1999-12-27 NO NO996492A patent/NO996492L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CO4940405A1 (es)	2000-07-24
CA2290973C (fr)	2003-06-17
TR199903282T2 (xx)	2000-08-21
HUP0002250A3 (en)	2001-01-29
EA199900963A1 (ru)	2000-08-28
NO996492D0 (no)	1999-12-27
KR100371730B1 (ko)	2003-02-07
ZA985709B (en)	2000-01-10
ID24673A (id)	2000-07-27
PT980241E (pt)	2004-03-31
EP0980241A1 (fr)	2000-02-23
DZ2544A1 (fr)	2003-02-08
AU7545098A (en)	1999-01-25
SK180599A3 (en)	2001-01-18
NZ501252A (en)	2004-11-26
WO1999001113A1 (fr)	1999-01-14
IS5266A (is)	1999-11-23
PL337807A1 (en)	2000-09-11
JP3585245B2 (ja)	2004-11-04
BR9809712A (pt)	2000-07-11
AP945A (en)	2001-02-28
HRP980378B1 (en)	2001-12-31
ES2210760T3 (es)	2004-07-01
ATE256457T1 (de)	2004-01-15
UA68350C2 (en)	2004-08-16
PA8454001A1 (es)	2000-05-24
GT199800090A (es)	1999-12-21
TNSN98123A1 (fr)	2005-03-15
KR20010013588A (fr)	2001-02-26
TW382597B (en)	2000-02-21
CN1261792A (zh)	2000-08-02
OA11246A (en)	2002-11-19
AR015916A1 (es)	2001-05-30
AU724635B2 (en)	2000-09-28
DK0980241T3 (da)	2004-04-05
BG103917A (bg)	2000-07-31
PE97299A1 (es)	1999-10-13
MA24586A1 (fr)	1998-12-31
AP9801279A0 (en)	1998-06-30
DE69820608D1 (de)	2004-01-29
EA001905B1 (ru)	2001-10-22
SK282914B6 (sk)	2003-01-09
NO996492L (no)	2000-02-29
HUP0002250A2 (hu)	2000-12-28
DE69820608T2 (de)	2004-12-23
MY119728A (en)	2005-07-29
HRP980378A2 (en)	1999-04-30
JP2000512316A (ja)	2000-09-19
EP0980241B1 (fr)	2003-12-17
UY25070A1 (es)	2000-12-29
CA2290973A1 (fr)	1999-01-14

Publication	Publication Date	Title
IL152330A0 (en)	2003-05-29	Sertraline salts and sustained-release dosage forms of sertraline
HU9403071D0 (en)	1994-12-28	Potentiation of drug response
HUP0105107A2 (en)	2002-06-29	Fast dispersing dosage forms free of gelatin
DE19681727T1 (de)	1999-05-12	Kapseln/Teilchen enthaltende Shampoo-Zusammensetzung
FI972555A7 (fi)	1997-06-16	Päällystettyjen tablettien valmistus
HUP0000759A3 (en)	2000-11-28	Dosage forms comprising separate portions of r- and s-enantiomers
HUT75246A (en)	1997-05-28	Soft gelatin pharmaceutical dosage form
SG54525A1 (en)	1998-11-16	Multiphase soft gelatin dosage form
AP9801278A0 (en)	1998-06-30	Delayed-release dosage forms of sertraline
HUP0002250A3 (en)	2001-01-29	Gelatine encapsulated solution dosage forms of sertraline
SI0980241T1 (en)	2004-04-30	Gelatine encapsulated solution dosage forms of sertraline
ZA948357B (en)	1996-04-24	Potentiation of drug response
ZA985707B (en)	2000-01-10	Sertraline salts and sustained-release dosage forms of sertraline.
GB9703750D0 (en)	1997-04-16	Treatment of haemorrhoids
HU9701917D0 (en)	1998-01-28	New compound of medicinal activity
AUPM590295A0 (en)	1995-11-02	Manufacture of pharmaceutical dosage forms
TW313845U (en)	1997-08-21	Improved structure of pacifier
BR9504107A (pt)	1997-09-09	Encapsulamento de peças anatômicas
TW398283U (en)	2000-07-11	Improved structure of mask
TW314782U (en)	1997-09-01	Improved structure of mask
ZA956361B (en)	1996-03-25	Dosing of animals
UA1957S (uk)	1998-04-30	Етикетка медичного препарату "аспаркам"
UA1951S (uk)	1998-04-30	Етикетка медичного препарату "валідол"
ZA9811474B (en)	1999-06-15	Novel amines of pharmaceutical agents